Prognostic factors in histiocytosis X
- PMID: 6972178
Prognostic factors in histiocytosis X
Abstract
It is now clear that the prognosis in children with histiocytosis X has improved considerable over the past few years. To be sure, patients with solitary lesions have an excellent prognosis. Whereas the outlook for patients with significant visceral involvement is not as good as those with bone lesions only, the outlook is by no means hopeless, as was once thought. A number of prognostic factors have been reviewed here. The most significant of these factors at the present time would appear to be age of onset of the disease, extent of involvement, the rapidity of progression of the disease, and, in particular, the presence or absence of dysfunction of such crucial organ systems as liver, lung, and hemopoietic system. Further studies of the significance of histologic features and immunologic findings are clearly needed to further our understanding of this disorder.
Similar articles
-
Histiocytosis X. Langerhans' cell histiocytosis.Hematol Oncol Clin North Am. 1987 Dec;1(4):737-51. Hematol Oncol Clin North Am. 1987. PMID: 3323181 Review.
-
Langerhans cell histiocytosis in children less than 2 years of age.Indian Pediatr. 1999 Jan;36(1):29-36. Indian Pediatr. 1999. PMID: 10709120
-
[Prognostic factors in histiocytosis X].Ann Pediatr (Paris). 1989 Oct;36(8):499-503. Ann Pediatr (Paris). 1989. PMID: 2683947 Review. French.
-
Histiocytosis-X in Saudi children.Indian J Cancer. 1991 Jun;28(2):53-60. Indian J Cancer. 1991. PMID: 1937547
-
[Histiocytosis X: historical review and therapeutic prospectives].Pediatr Med Chir. 1984 Mar-Apr;6(2):185-91. Pediatr Med Chir. 1984. PMID: 6335752 Italian.
Cited by
-
Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement.BMC Cancer. 2020 Sep 23;20(1):911. doi: 10.1186/s12885-020-07421-z. BMC Cancer. 2020. PMID: 32967635 Free PMC article.
-
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.Blood Adv. 2023 Feb 28;7(4):664-679. doi: 10.1182/bloodadvances.2022007947. Blood Adv. 2023. PMID: 36083130 Free PMC article.
-
The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial.BMC Cancer. 2020 May 18;20(1):433. doi: 10.1186/s12885-020-06872-8. BMC Cancer. 2020. PMID: 32423455 Free PMC article. Clinical Trial.
-
High risk Langerhans cell histiocytosis in children: the role of salvage in improving the outcome. A single center experience.Orphanet J Rare Dis. 2024 Jun 24;19(1):242. doi: 10.1186/s13023-024-03232-8. Orphanet J Rare Dis. 2024. PMID: 38910253 Free PMC article.
-
Bone marrow infiltration in Langerhan's cell histiocytosis - An unusual but important determinant for staging and treatment.Int J Hematol Oncol Stem Cell Res. 2015 Oct 1;9(4):193-7. Int J Hematol Oncol Stem Cell Res. 2015. PMID: 26865930 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous